These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20065261)

  • 21. Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.
    Gasior M; Bond M; Malamut R
    Postgrad Med; 2016 Jan; 128(1):85-96. PubMed ID: 26566680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SCOPE of Pain: An Evaluation of an Opioid Risk Evaluation and Mitigation Strategy Continuing Education Program.
    Alford DP; Zisblatt L; Ng P; Hayes SM; Peloquin S; Hardesty I; White JL
    Pain Med; 2016 Jan; 17(1):52-63. PubMed ID: 26304703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid Prescribing for Chronic Pain--Achieving the Right Balance through Education.
    Alford DP
    N Engl J Med; 2016 Jan; 374(4):301-3. PubMed ID: 26816007
    [No Abstract]   [Full Text] [Related]  

  • 24. Societal economic benefits associated with an extended-release opioid with abuse-deterrent technology in the United States.
    Kirson NY; Shei A; White AG; Birnbaum HG; Ben-Joseph R; Rossiter LF; Michna E
    Pain Med; 2014 Sep; 15(9):1450-4. PubMed ID: 25041231
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety plan for opioids meets resistance: opioid-linked deaths continue to soar.
    Kuehn BM
    JAMA; 2010 Feb; 303(6):495-7. PubMed ID: 20145218
    [No Abstract]   [Full Text] [Related]  

  • 26. Pain treatment agreements.
    Rowe W
    Am J Bioeth; 2010 Nov; 10(11):3-4. PubMed ID: 21104544
    [No Abstract]   [Full Text] [Related]  

  • 27. ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes.
    Cepeda MS; Coplan PM; Kopper NW; Maziere JY; Wedin GP; Wallace LE
    Pain Med; 2017 Jan; 18(1):78-85. PubMed ID: 27373304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combatting Massachusetts's Opioid Epidemic: Reducing the Social Stigma of Addiction Through Increased Access to Voluntary Treatment Services and Expansion of Mandatory Clinician Education Programs.
    Pearlman J
    Am J Law Med; 2016 Nov; 42(4):835-857. PubMed ID: 29086651
    [No Abstract]   [Full Text] [Related]  

  • 29. Blueprint for prescriber continuing education program.
    Center For Drug Evaluation And Research Food And Drug Administration
    J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):127-30. PubMed ID: 22764849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating potentially aberrant outpatient prescriptions for extended-release oxycodone.
    Goodman FD; Glassman P
    Am J Health Syst Pharm; 2005 Dec; 62(24):2604-8. PubMed ID: 16333058
    [No Abstract]   [Full Text] [Related]  

  • 31. NEJM Knowledge+ Pain Management and Opioids - A New Adaptive Learning Module.
    Hamnvik OR; Alford DP; Ryan CT; Hardesty IT; Drazen JM
    N Engl J Med; 2019 Apr; 380(16):1576-1577. PubMed ID: 30969501
    [No Abstract]   [Full Text] [Related]  

  • 32. Controlling the Swing of the Opioid Pendulum.
    Comerci G; Katzman J; Duhigg D
    N Engl J Med; 2018 Feb; 378(8):691-693. PubMed ID: 29466151
    [No Abstract]   [Full Text] [Related]  

  • 33. When less is more: Opioid use in the emergency department.
    Patanwala AE
    Am J Health Syst Pharm; 2019 Oct; 76(22):1812-1813. PubMed ID: 31665766
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug monitoring programs help patients and dentists.
    Hawaii Dent Assoc J; 2016; ():14-5. PubMed ID: 27265959
    [No Abstract]   [Full Text] [Related]  

  • 35. A Proactive Response to Prescription Opioid Abuse.
    Califf RM; Woodcock J; Ostroff S
    N Engl J Med; 2016 Apr; 374(15):1480-5. PubMed ID: 26845291
    [No Abstract]   [Full Text] [Related]  

  • 36. Training not required to prescribe sustained-release opioids.
    J Am Vet Med Assoc; 2013 May; 242(9):1191. PubMed ID: 23738379
    [No Abstract]   [Full Text] [Related]  

  • 37. The Other Side of the Opioid Debate: Treating Older Adults With Chronic Pain.
    Martin CM
    Consult Pharm; 2018 Sep; 33(9):478-483. PubMed ID: 30185288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marshaling FDA Benefit-Risk Expertise to Address the Current Opioid Abuse Epidemic.
    Gottlieb S; Woodcock J
    JAMA; 2017 Aug; 318(5):421-422. PubMed ID: 28687816
    [No Abstract]   [Full Text] [Related]  

  • 39. Coupling Policymaking with Evaluation - The Case of the Opioid Crisis.
    Barnett ML; Gray J; Zink A; Jena AB
    N Engl J Med; 2017 Dec; 377(24):2306-2309. PubMed ID: 29236636
    [No Abstract]   [Full Text] [Related]  

  • 40. Can Regulation Solve the Opioid Crisis?
    Muller LS; Inci SB
    Prof Case Manag; 2018; 23(2):88-91. PubMed ID: 29381675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.